Inhibition of nuclear factor-kappaB and p38 mitogen-activated protein kinase does not always have adverse effects on

Adrian O'Sullivan1, Diarmuid O'Malley, John Coffey

  • 1Department of Academic Surgery, University College Cork, Cork, Ireland. awmos@btinternet.com

Surgical Infections
|August 7, 2009
PubMed
Abstract

Insights

Inhibiting p38 mitogen-activated protein kinase (MAPK) and nuclear factor-kappaB (NF-kappaB) did not impair wound healing in mice. These findings suggest potential safety for treating inflammatory and septic conditions.

Area of Science:

  • Molecular Biology
  • Immunology
  • Wound Healing Research

Background:

  • p38 MAPK and NF-kappaB activation are crucial for inflammation and fibroblast function in wound healing.
  • Inhibiting these pathways may offer sepsis treatment strategies but could affect healing.
  • This study investigated the impact of p38 and NF-kappaB inhibition on incision healing.

Purpose of the Study:

  • To evaluate the effects of inhibiting p38 activation and NF-kappaB translation on incision healing.
  • To determine if these inhibitors interfere with the inflammatory processes essential for wound repair.

Main Methods:

  • Male mice underwent dorsal slit incisions and were randomized into control, p38 inhibitor (SB-202190), and NF-kappaB inhibitor (SN-50) groups.
  • Incision sites were assessed for histologic changes and breaking strength at 3 and 7 days.
  • Circulating cytokine levels (TNF-alpha, IL-6) were analyzed.

Main Results:

  • Neither SB-202190 nor SN-50 significantly affected incision strength or histologic healing.
  • Cytokine levels showed no significant differences at day 3; TNF-alpha was higher in the SB-202190 group at day 7.
  • No adverse effects on inflammation or collagen deposition were observed.

Conclusions:

  • Inhibition of p38 and NF-kappaB pathways does not adversely impact incision healing.
  • These findings suggest that targeting these pathways may be safe for clinical use in inflammatory and septic conditions.
  • The inflammation necessary for normal healing appears unaffected by these inhibitors.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...